Real-world Efficacy and Safety of Apremilast Monotherapy in the Management of Moderate-to-severe Psoriasis

INTRODUCTION: Apremilast is the new oral drug in the management of moderate-to-severe plaque psoriasis with well-established effectiveness and safety in long-term clinical trials and a few real-world studies. However, its effectiveness and safety in Indian setup have not been reported yet. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Bela J., Mistry, Deval, Chaudhary, Navin, Shah, Shikha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001393/
https://www.ncbi.nlm.nih.gov/pubmed/32055509
http://dx.doi.org/10.4103/idoj.IDOJ_169_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001393/
https://www.ncbi.nlm.nih.gov/pubmed/32055509
http://dx.doi.org/10.4103/idoj.IDOJ_169_19

Ejemplares similares